Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	mRNA binding	TRA2B LUC7L LUC7L2 SRSF4	8.05e-04	694	13	4	GO:0003729
GeneOntologyBiologicalProcess	mRNA splicing, via spliceosome	TRA2B TRA2A LUC7L CDK13 LUC7L2 SRSF4	4.06e-08	358	13	6	GO:0000398
GeneOntologyBiologicalProcess	RNA splicing, via transesterification reactions with bulged adenosine as nucleophile	TRA2B TRA2A LUC7L CDK13 LUC7L2 SRSF4	4.06e-08	358	13	6	GO:0000377
GeneOntologyBiologicalProcess	RNA splicing, via transesterification reactions	TRA2B TRA2A LUC7L CDK13 LUC7L2 SRSF4	4.34e-08	362	13	6	GO:0000375
GeneOntologyBiologicalProcess	RNA splicing	TRA2B TRA2A LUC7L CDK13 LUC7L2 SRSF4	2.99e-07	502	13	6	GO:0008380
GeneOntologyBiologicalProcess	mRNA processing	TRA2B TRA2A LUC7L CDK13 LUC7L2 SRSF4	5.17e-07	551	13	6	GO:0006397
GeneOntologyBiologicalProcess	mRNA metabolic process	TRA2B TRA2A LUC7L CDK13 LUC7L2 SRSF4	9.96e-06	917	13	6	GO:0016071
GeneOntologyBiologicalProcess	regulation of mRNA splicing, via spliceosome	TRA2B TRA2A SRSF4	6.53e-05	129	13	3	GO:0048024
GeneOntologyBiologicalProcess	regulation of mRNA processing	TRA2B TRA2A SRSF4	1.19e-04	158	13	3	GO:0050684
GeneOntologyBiologicalProcess	embryonic brain development	TRA2B PRICKLE1	1.47e-04	29	13	2	GO:1990403
GeneOntologyBiologicalProcess	RNA processing	TRA2B TRA2A LUC7L CDK13 LUC7L2 SRSF4	1.61e-04	1500	13	6	GO:0006396
GeneOntologyBiologicalProcess	negative regulation of stem cell differentiation	PRICKLE1 CDK13	1.91e-04	33	13	2	GO:2000737
GeneOntologyBiologicalProcess	regulation of RNA splicing	TRA2B TRA2A SRSF4	2.65e-04	207	13	3	GO:0043484
GeneOntologyBiologicalProcess	positive regulation of mRNA splicing, via spliceosome	TRA2B TRA2A	3.42e-04	44	13	2	GO:0048026
GeneOntologyBiologicalProcess	positive regulation of mRNA processing	TRA2B TRA2A	4.24e-04	49	13	2	GO:0050685
GeneOntologyBiologicalProcess	mRNA splice site recognition	LUC7L LUC7L2	4.78e-04	52	13	2	GO:0006376
GeneOntologyBiologicalProcess	positive regulation of RNA splicing	TRA2B TRA2A	7.01e-04	63	13	2	GO:0033120
GeneOntologyBiologicalProcess	alternative mRNA splicing, via spliceosome	TRA2B CDK13	1.10e-03	79	13	2	GO:0000380
GeneOntologyBiologicalProcess	regulation of stem cell differentiation	PRICKLE1 CDK13	1.72e-03	99	13	2	GO:2000736
GeneOntologyBiologicalProcess	spliceosomal complex assembly	LUC7L LUC7L2	1.72e-03	99	13	2	GO:0000245
GeneOntologyBiologicalProcess	regulation of mRNA metabolic process	TRA2B TRA2A SRSF4	2.40e-03	443	13	3	GO:1903311
GeneOntologyCellularComponent	spliceosomal complex	TRA2B TRA2A LUC7L LUC7L2	7.23e-06	215	13	4	GO:0005681
GeneOntologyCellularComponent	U2-type prespliceosome	LUC7L LUC7L2	5.43e-05	18	13	2	GO:0071004
GeneOntologyCellularComponent	prespliceosome	LUC7L LUC7L2	5.43e-05	18	13	2	GO:0071010
GeneOntologyCellularComponent	nuclear speck	RBBP6 CDK13 LUC7L2 SRSF4	1.10e-04	431	13	4	GO:0016607
GeneOntologyCellularComponent	U1 snRNP	LUC7L LUC7L2	1.86e-04	33	13	2	GO:0005685
GeneOntologyCellularComponent	ribonucleoprotein complex	TRA2B TRA2A LUC7L LUC7L2 SRSF4	5.27e-04	1194	13	5	GO:1990904
GeneOntologyCellularComponent	nuclear protein-containing complex	TRA2B TRA2A LUC7L CDK13 LUC7L2	1.01e-03	1377	13	5	GO:0140513
GeneOntologyCellularComponent	spliceosomal snRNP complex	LUC7L LUC7L2	1.58e-03	96	13	2	GO:0097525
GeneOntologyCellularComponent	U2-type spliceosomal complex	LUC7L LUC7L2	1.61e-03	97	13	2	GO:0005684
GeneOntologyCellularComponent	nuclear body	RBBP6 CDK13 LUC7L2 SRSF4	1.81e-03	903	13	4	GO:0016604
GeneOntologyCellularComponent	small nuclear ribonucleoprotein complex	LUC7L LUC7L2	1.95e-03	107	13	2	GO:0030532
GeneOntologyCellularComponent	Sm-like protein family complex	LUC7L LUC7L2	2.41e-03	119	13	2	GO:0120114
Domain	Luc7-rel	LUC7L LUC7L2	1.34e-06	3	13	2	IPR004882
Domain	LUC7	LUC7L LUC7L2	1.34e-06	3	13	2	PF03194
Domain	RRM_1	TRA2B TRA2A SRSF4	3.59e-04	208	13	3	PF00076
Domain	RRM	TRA2B TRA2A SRSF4	4.06e-04	217	13	3	SM00360
Domain	RRM_dom	TRA2B TRA2A SRSF4	4.63e-04	227	13	3	IPR000504
Domain	RRM	TRA2B TRA2A SRSF4	4.81e-04	230	13	3	PS50102
Domain	-	TRA2B TRA2A SRSF4	5.72e-04	244	13	3	3.30.70.330
Domain	Nucleotide-bd_a/b_plait	TRA2B TRA2A SRSF4	6.73e-04	258	13	3	IPR012677
Pathway	KEGG_SPLICEOSOME	TRA2B TRA2A SRSF4	5.77e-05	127	9	3	M2044
Pathway	REACTOME_RHOBTB1_GTPASE_CYCLE	TRA2B RBBP6	9.10e-05	23	9	2	M41817
Pathway	REACTOME_RHOBTB1_GTPASE_CYCLE	TRA2B RBBP6	1.08e-04	25	9	2	MM15608
Pathway	REACTOME_RHOBTB_GTPASE_CYCLE	TRA2B RBBP6	2.13e-04	35	9	2	M41738
Pathway	REACTOME_RHOBTB_GTPASE_CYCLE	TRA2B RBBP6	2.39e-04	37	9	2	MM15683
Pathway	WP_MRNA_PROCESSING	TRA2B RSRC2 SRSF4	2.37e-03	451	9	3	MM15946
Pathway	WP_MRNA_PROCESSING	TRA2B SRSF4	2.74e-03	126	9	2	M39406
Pubmed	The protein interaction landscape of the human CMGC kinase group.	TRA2B TRA2A RBBP6 LUC7L CDK13 LUC7L2 GPATCH8 RSRC2 SRSF4	3.21e-13	695	13	9	23602568
Pubmed	RNA-binding proteins with basic-acidic dipeptide (BAD) domains self-assemble and aggregate in Alzheimer's disease.	TRA2B TRA2A RBBP6 LUC7L NKTR GPATCH8 RSRC2 SRSF4	3.53e-11	713	13	8	29802200
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	TRA2B TRA2A RBBP6 LUC7L CDK13 LUC7L2 NKTR GPATCH8 SRSF4	8.31e-11	1294	13	9	30804502
Pubmed	The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.	TRA2B TRA2A RBBP6 CDK13 LUC7L2 GPATCH8 RSRC2 SRSF4	9.43e-11	807	13	8	22681889
Pubmed	SNIP1 Recruits TET2 to Regulate c-MYC Target Genes and Cellular DNA Damage Response.	TRA2B TRA2A CDK13 LUC7L2 NKTR SRSF4	2.64e-10	259	13	6	30404004
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	TRA2B TRA2A RBBP6 LUC7L LUC7L2 GPATCH8 RSRC2 SRSF4	9.58e-10	1082	13	8	38697112
Pubmed	Characterizing ZC3H18, a Multi-domain Protein at the Interface of RNA Production and Destruction Decisions.	TRA2B TRA2A RBBP6 LUC7L LUC7L2 RSRC2 SRSF4	2.71e-09	731	13	7	29298432
Pubmed	Human RNPS1 and its associated factors: a versatile alternative pre-mRNA splicing regulator in vivo.	TRA2B NKTR GPATCH8	6.72e-09	11	13	3	14729963
Pubmed	SETD1A Methyltransferase Is Physically and Functionally Linked to the DNA Damage Repair Protein RAD18.	TRA2B TRA2A RBBP6 LUC7L SRSF4	2.31e-08	251	13	5	31076518
Pubmed	The E3 ubiquitin ligase UBR5 interacts with the H/ACA ribonucleoprotein complex and regulates ribosomal RNA biogenesis in embryonic stem cells.	TRA2A LUC7L LUC7L2 SRSF4	5.28e-08	104	13	4	31365120
Pubmed	ATAC and Mediator coactivators form a stable complex and regulate a set of non-coding RNA genes.	TRA2B TRA2A LUC7L SRSF4	5.93e-08	107	13	4	20508642
Pubmed	Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells.	TRA2B RBBP6 LUC7L CDK13 LUC7L2 GPATCH8	7.31e-08	665	13	6	30457570
Pubmed	Charting the landscape of tandem BRCT domain-mediated protein interactions.	TRA2B TRA2A LUC7L CDK13 LUC7L2 SRSF4	7.65e-08	670	13	6	22990118
Pubmed	PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation.	TRA2B RBBP6 LUC7L CDK13 LUC7L2 SRSF4	8.20e-08	678	13	6	30209976
Pubmed	ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex.	TRA2B TRA2A LUC7L NKTR SRSF4	9.02e-08	330	13	5	33301849
Pubmed	Matrix-screening reveals a vast potential for direct protein-protein interactions among RNA binding proteins.	TRA2B RBBP6 LUC7L CDK13 LUC7L2 SRSF4	1.20e-07	723	13	6	34133714
Pubmed	Human Tra2 proteins are sequence-specific activators of pre-mRNA splicing.	TRA2B TRA2A	1.29e-07	2	13	2	9546399
Pubmed	Differential Effects of Tra2ß Isoforms on HIV-1 RNA Processing and Expression.	TRA2B TRA2A	1.29e-07	2	13	2	25970345
Pubmed	TRA2A Promoted Paclitaxel Resistance and Tumor Progression in Triple-Negative Breast Cancers via Regulating Alternative Splicing.	TRA2A RSRC2	1.29e-07	2	13	2	28416606
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	TRA2B TRA2A RBBP6 LUC7L CDK13	1.41e-07	361	13	5	26167880
Pubmed	BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.	TRA2B TRA2A RBBP6 LUC7L LUC7L2 NKTR SRSF4	1.55e-07	1318	13	7	30463901
Pubmed	A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome.	TRA2B PRICKLE1 CDK13 GPATCH8 RSRC2	2.98e-07	420	13	5	28065597
Pubmed	Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.	TRA2B TRA2A RBBP6 LUC7L LUC7L2 SRSF4	3.04e-07	847	13	6	35850772
Pubmed	Functional analyses of human LUC7-like proteins involved in splicing regulation and myeloid neoplasms.	LUC7L LUC7L2	3.87e-07	3	13	2	33852859
Pubmed	Tra2-mediated recognition of HIV-1 5' splice site D3 as a key factor in the processing of vpr mRNA.	TRA2B TRA2A	3.87e-07	3	13	2	23255807
Pubmed	Identification of evolutionarily conserved exons as regulated targets for the splicing activator tra2β in development.	TRA2B TRA2A	3.87e-07	3	13	2	22194695
Pubmed	Dynamic protein-protein interaction wiring of the human spliceosome.	TRA2B TRA2A LUC7L SRSF4	6.86e-07	197	13	4	22365833
Pubmed	The interactome of CLUH reveals its association to SPAG5 and its co-translational proximity to mitochondrial proteins.	TRA2B TRA2A LUC7L2 SRSF4	7.73e-07	203	13	4	35012549
Pubmed	Dephosphorylated SRp38 acts as a splicing repressor in response to heat shock.	TRA2B TRA2A	7.74e-07	4	13	2	14765198
Pubmed	The Brd4 extraterminal domain confers transcription activation independent of pTEFb by recruiting multiple proteins, including NSD3.	LUC7L LUC7L2 RSRC2	1.18e-06	57	13	3	21555454
Pubmed	Angulin proteins ILDR1 and ILDR2 regulate alternative pre-mRNA splicing through binding to splicing factors TRA2A, TRA2B, or SRSF1.	TRA2B TRA2A	1.29e-06	5	13	2	28785060
Pubmed	Interactome analyses revealed that the U1 snRNP machinery overlaps extensively with the RNAP II machinery and contains multiple ALS/SMA-causative proteins.	TRA2B TRA2A GPATCH8 SRSF4	1.61e-06	244	13	4	29884807
Pubmed	Acetylation of ELF5 suppresses breast cancer progression by promoting its degradation and targeting CCND1.	TRA2B TRA2A RBBP6 LUC7L SRSF4	2.61e-06	653	13	5	33742100
Pubmed	SMYD3 Impedes Small Cell Lung Cancer Sensitivity to Alkylation Damage through RNF113A Methylation-Phosphorylation Cross-talk.	TRA2B RBBP6 LUC7L CDK13 LUC7L2	2.65e-06	655	13	5	35819319
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	TRA2B RBBP6 LUC7L LUC7L2 RSRC2 SRSF4	2.90e-06	1247	13	6	27684187
Pubmed	R2TP/Prefoldin-like component RUVBL1/RUVBL2 directly interacts with ZNHIT2 to regulate assembly of U5 small nuclear ribonucleoprotein.	LUC7L LUC7L2 GPATCH8 SRSF4	3.65e-06	300	13	4	28561026
Pubmed	Proteomic analysis of steady-state nuclear hormone receptor coactivator complexes.	TRA2B RBBP6 LUC7L2	3.96e-06	85	13	3	16051665
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	TRA2A LUC7L CDK13 LUC7L2 NKTR RSRC2	5.02e-06	1371	13	6	36244648
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	TRA2B TRA2A LUC7L CDK13 LUC7L2 SRSF4	8.29e-06	1496	13	6	32877691
Pubmed	Proteomic Analysis of the EWS-Fli-1 Interactome Reveals the Role of the Lysosome in EWS-Fli-1 Turnover.	TRA2B TRA2A RBBP6 GPATCH8	1.44e-05	425	13	4	24999758
Pubmed	RioK1, a new interactor of protein arginine methyltransferase 5 (PRMT5), competes with pICln for binding and modulates PRMT5 complex composition and substrate specificity.	TRA2B LUC7L LUC7L2 SRSF4	1.44e-05	425	13	4	21081503
Pubmed	Neuronal-specific deficiency of the splicing factor Tra2b causes apoptosis in neurogenic areas of the developing mouse brain.	TRA2B TRA2A	1.54e-05	16	13	2	24586484
Pubmed	TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1.	TRA2B RBBP6 LUC7L CDK13 LUC7L2	1.61e-05	949	13	5	36574265
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	TRA2B TRA2A RBBP6 CDK13 GPATCH8	2.21e-05	1014	13	5	32416067
Pubmed	High-throughput analyses of hnRNP H1 dissects its multi-functional aspect.	TRA2B TRA2A LUC7L LUC7L2 SRSF4	2.28e-05	1021	13	5	26760575
Pubmed	Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents.	LUC7L LUC7L2 GPATCH8 SRSF4	2.44e-05	486	13	4	30940648
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	TRA2B TRA2A RBBP6 CDK13	2.79e-05	503	13	4	16964243
Pubmed	The cellular EJC interactome reveals higher-order mRNP structure and an EJC-SR protein nexus.	TRA2B TRA2A SRSF4	3.11e-05	169	13	3	23084401
Pubmed	Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation.	TRA2B LUC7L SRSF4	3.75e-05	180	13	3	30110629
Pubmed	The HIV-1 Tat protein recruits a ubiquitin ligase to reorganize the 7SK snRNP for transcriptional activation.	TRA2B TRA2A LUC7L CDK13 SRSF4	4.09e-05	1153	13	5	29845934
Pubmed	Delineating the HMGB1 and HMGB2 interactome in prostate and ovary epithelial cells and its relationship with cancer.	TRA2B TRA2A NKTR	4.27e-05	188	13	3	29721183
Pubmed	Folate receptor α increases chemotherapy resistance through stabilizing MDM2 in cooperation with PHB2 that is overcome by MORAb-202 in gastric cancer.	RBBP6 LUC7L LUC7L2	5.61e-05	206	13	3	34185411
Pubmed	Large-scale mapping of human protein-protein interactions by mass spectrometry.	TRA2B LUC7L LUC7L2 GPATCH8 SRSF4	6.84e-05	1284	13	5	17353931
Pubmed	The Activation-Induced Assembly of an RNA/Protein Interactome Centered on the Splicing Factor U2AF2 Regulates Gene Expression in Human CD4 T Cells.	TRA2B TRA2A SRSF4	8.71e-05	239	13	3	26641092
Pubmed	Lysine acetylation targets protein complexes and co-regulates major cellular functions.	TRA2B SRSF4	9.00e-05	38	13	2	19608861
Pubmed	FOXA1 Directs H3K4 Monomethylation at Enhancers via Recruitment of the Methyltransferase MLL3.	TRA2A LUC7L LUC7L2	9.72e-05	248	13	3	27926873
Pubmed	ATG5 is required for B cell polarization and presentation of particulate antigens.	TRA2A RBBP6 NKTR GPATCH8	1.01e-04	701	13	4	30196744
Pubmed	A Compendium of RNA-Binding Proteins that Regulate MicroRNA Biogenesis.	TRA2B TRA2A RBBP6	1.04e-04	254	13	3	28431233
Pubmed	Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization.	TRA2B TRA2A LUC7L2	1.06e-04	255	13	3	15324660
Pubmed	Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15.	TRA2B TRA2A GPATCH8 SRSF4	1.09e-04	714	13	4	28302793
Pubmed	Insights into the ubiquitin-proteasome system of human embryonic stem cells.	LUC7L LUC7L2 SRSF4	1.24e-04	269	13	3	29511261
Pubmed	Regulation of alternative splicing by SRrp86 and its interacting proteins.	TRA2B SRSF4	2.03e-04	57	13	2	14559993
Pubmed	Conserved expression of ultra-conserved noncoding RNA in mammalian nervous system.	TRA2B TRA2A	2.26e-04	60	13	2	29055695
Pubmed	ARIH2 Is a Vif-Dependent Regulator of CUL5-Mediated APOBEC3G Degradation in HIV Infection.	TRA2B LUC7L LUC7L2	2.38e-04	336	13	3	31253590
Pubmed	A genome-wide in situ hybridization map of RNA-binding proteins reveals anatomically restricted expression in the developing mouse brain.	TRA2B TRA2A SRSF4	2.61e-04	347	13	3	16033648
Pubmed	SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes.	TRA2B TRA2A SRSF4	2.75e-04	353	13	3	27545878
Pubmed	TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions.	TRA2B TRA2A RBBP6 SRSF4	2.90e-04	922	13	4	27609421
Pubmed	Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation.	TRA2B TRA2A SRSF4	2.94e-04	361	13	3	30344098
Pubmed	A systematic screen for CDK4/6 substrates links FOXM1 phosphorylation to senescence suppression in cancer cells.	TRA2B TRA2A	3.34e-04	73	13	2	22094256
Pubmed	A protein interaction network links GIT1, an enhancer of huntingtin aggregation, to Huntington's disease.	LUC7L LUC7L2	3.52e-04	75	13	2	15383276
Interaction	CLK2 interactions	TRA2B TRA2A RBBP6 LUC7L LUC7L2 NKTR GPATCH8 SRSF4	8.21e-14	195	13	8	int:CLK2
Interaction	SRPK2 interactions	TRA2B TRA2A RBBP6 LUC7L CDK13 LUC7L2 NKTR GPATCH8 RSRC2 SRSF4	7.93e-13	717	13	10	int:SRPK2
Interaction	SRSF6 interactions	TRA2B TRA2A RBBP6 LUC7L CDK13 LUC7L2 NKTR GPATCH8 SRSF4	2.29e-12	503	13	9	int:SRSF6
Interaction	CLK3 interactions	TRA2B TRA2A RBBP6 LUC7L LUC7L2 GPATCH8 SRSF4	2.73e-11	220	13	7	int:CLK3
Interaction	RNPS1 interactions	TRA2B TRA2A RBBP6 LUC7L LUC7L2 NKTR GPATCH8 SRSF4	4.30e-11	425	13	8	int:RNPS1
Interaction	LUC7L interactions	TRA2A RBBP6 LUC7L LUC7L2 PRM2 NKTR GPATCH8	5.33e-11	242	13	7	int:LUC7L
Interaction	DHX8 interactions	RBBP6 CDK13 LUC7L2 NKTR GPATCH8 RSRC2 SRSF4	1.99e-10	292	13	7	int:DHX8
Interaction	SRSF4 interactions	TRA2B TRA2A RBBP6 CDK13 NKTR GPATCH8 SRSF4	2.40e-10	300	13	7	int:SRSF4
Interaction	SNRNP70 interactions	TRA2B TRA2A RBBP6 LUC7L LUC7L2 NKTR GPATCH8 RSRC2 SRSF4	9.11e-10	984	13	9	int:SNRNP70
Interaction	SRSF11 interactions	TRA2B TRA2A LUC7L LUC7L2 GPATCH8 SRSF4	1.57e-09	203	13	6	int:SRSF11
Interaction	SNIP1 interactions	TRA2B TRA2A CDK13 LUC7L2 NKTR GPATCH8 SRSF4	2.38e-09	417	13	7	int:SNIP1
Interaction	SRSF7 interactions	TRA2B TRA2A RBBP6 LUC7L LUC7L2 NKTR SRSF4	2.72e-09	425	13	7	int:SRSF7
Interaction	SRSF8 interactions	TRA2B TRA2A LUC7L LUC7L2 SRSF4	3.06e-09	98	13	5	int:SRSF8
Interaction	SNRPC interactions	TRA2B TRA2A RBBP6 LUC7L NKTR GPATCH8 SRSF4	3.46e-09	440	13	7	int:SNRPC
Interaction	MECP2 interactions	TRA2B TRA2A RBBP6 LUC7L LUC7L2 NKTR GPATCH8 RSRC2 SRSF4	9.73e-09	1287	13	9	int:MECP2
Interaction	ZC3H18 interactions	TRA2B TRA2A RBBP6 LUC7L LUC7L2 NKTR RSRC2 SRSF4	1.32e-08	877	13	8	int:ZC3H18
Interaction	PNN interactions	TRA2A RBBP6 LUC7L LUC7L2 NKTR SRSF4	1.69e-08	302	13	6	int:PNN
Interaction	BARD1 interactions	TRA2B TRA2A LUC7L CDK13 LUC7L2 SRSF4	2.53e-08	323	13	6	int:BARD1
Interaction	TRA2A interactions	TRA2B TRA2A RBBP6 LUC7L LUC7L2 SRSF4	2.87e-08	330	13	6	int:TRA2A
Interaction	U2AF2 interactions	TRA2B TRA2A LUC7L LUC7L2 NKTR GPATCH8 SRSF4	5.15e-08	651	13	7	int:U2AF2
Interaction	SRPK3 interactions	TRA2A LUC7L CDK13 LUC7L2 SRSF4	8.55e-08	190	13	5	int:SRPK3
Interaction	SRRM2 interactions	TRA2B TRA2A RBBP6 LUC7L LUC7L2 SRSF4	2.10e-07	462	13	6	int:SRRM2
Interaction	DDX23 interactions	RBBP6 CDK13 NKTR GPATCH8 RSRC2 SRSF4	2.63e-07	480	13	6	int:DDX23
Interaction	SNRPA interactions	TRA2B TRA2A RBBP6 LUC7L NKTR SRSF4	2.70e-07	482	13	6	int:SNRPA
Interaction	MYCN interactions	TRA2B TRA2A RBBP6 LUC7L CDK13 LUC7L2 GPATCH8 SRSF4	4.30e-07	1373	13	8	int:MYCN
Interaction	SRSF10 interactions	TRA2B TRA2A LUC7L LUC7L2 SRSF4	4.99e-07	271	13	5	int:SRSF10
Interaction	GPATCH8 interactions	LUC7L LUC7L2 GPATCH8 SRSF4	6.91e-07	115	13	4	int:GPATCH8
Interaction	SRSF1 interactions	TRA2B TRA2A LUC7L CDK13 LUC7L2 SRSF4	7.23e-07	570	13	6	int:SRSF1
Interaction	SAP18 interactions	TRA2B TRA2A RBBP6 NKTR GPATCH8	8.95e-07	305	13	5	int:SAP18
Interaction	PPIG interactions	TRA2A RBBP6 LUC7L SRSF4	1.03e-06	127	13	4	int:PPIG
Interaction	SRRM4 interactions	LUC7L LUC7L2 SRSF4	1.61e-06	37	13	3	int:SRRM4
Interaction	RC3H2 interactions	TRA2B RBBP6 LUC7L CDK13 LUC7L2 SRSF4	1.81e-06	667	13	6	int:RC3H2
Interaction	LUC7L2 interactions	TRA2B TRA2A LUC7L LUC7L2 GPATCH8	1.84e-06	353	13	5	int:LUC7L2
Interaction	NKAPD1 interactions	TRA2B TRA2A NKTR SRSF4	2.65e-06	161	13	4	int:NKAPD1
Interaction	RNASEH1 interactions	LUC7L CDK13 NKTR	3.34e-06	47	13	3	int:RNASEH1
Interaction	YTHDC1 interactions	TRA2B PRICKLE1 TRA2A RBBP6 SRSF4	4.16e-06	417	13	5	int:YTHDC1
Interaction	DOT1L interactions	TRA2B TRA2A RBBP6 LUC7L LUC7L2 SRSF4	5.45e-06	807	13	6	int:DOT1L
Interaction	THRAP3 interactions	TRA2A RBBP6 LUC7L LUC7L2 SRSF4	5.58e-06	443	13	5	int:THRAP3
Interaction	ZBTB2 interactions	TRA2B TRA2A LUC7L NKTR SRSF4	6.03e-06	450	13	5	int:ZBTB2
Interaction	TADA2A interactions	TRA2B TRA2A LUC7L SRSF4	6.03e-06	198	13	4	int:TADA2A
Interaction	RAD18 interactions	TRA2B TRA2A RBBP6 LUC7L SRSF4	6.50e-06	457	13	5	int:RAD18
Interaction	JMJD6 interactions	TRA2B LUC7L LUC7L2 RSRC2	6.92e-06	205	13	4	int:JMJD6
Interaction	SRPK1 interactions	TRA2B LUC7L LUC7L2 RSRC2 SRSF4	8.00e-06	477	13	5	int:SRPK1
Interaction	RBBP6 interactions	TRA2A RBBP6 LUC7L SRSF4	8.51e-06	216	13	4	int:RBBP6
Interaction	CLK1 interactions	TRA2B TRA2A RBBP6 SRSF4	8.98e-06	219	13	4	int:CLK1
Interaction	NR2C2 interactions	TRA2B TRA2A RBBP6 LUC7L LUC7L2 NKTR SRSF4	9.22e-06	1403	13	7	int:NR2C2
Interaction	BRD3 interactions	TRA2B TRA2A RBBP6 LUC7L2 RSRC2	9.49e-06	494	13	5	int:BRD3
Interaction	EIF4A3 interactions	TRA2B TRA2A RBBP6 GPATCH8 SRSF4	9.96e-06	499	13	5	int:EIF4A3
Interaction	CEBPB interactions	TRA2B TRA2A LUC7L CDK13 LUC7L2 GPATCH8 SRSF4	1.11e-05	1443	13	7	int:CEBPB
Interaction	SRSF3 interactions	TRA2B TRA2A RBBP6 CDK13 SRSF4	1.24e-05	522	13	5	int:SRSF3
Interaction	CPSF6 interactions	TRA2B TRA2A RBBP6 LUC7L2 NKTR	1.29e-05	526	13	5	int:CPSF6
Interaction	ATXN1 interactions	TRA2B RBBP6 LUC7L CDK13 LUC7L2 GPATCH8	2.32e-05	1039	13	6	int:ATXN1
Interaction	RBM39 interactions	TRA2B TRA2A LUC7L2 NKTR GPATCH8 SRSF4	2.36e-05	1042	13	6	int:RBM39
Interaction	NKTR interactions	LUC7L NKTR SRSF4	2.38e-05	90	13	3	int:NKTR
Interaction	PPIE interactions	TRA2B LUC7L LUC7L2 SRSF4	2.43e-05	282	13	4	int:PPIE
Interaction	RBM23 interactions	LUC7L PRM2 SRSF4	2.72e-05	94	13	3	int:RBM23
Interaction	NUP43 interactions	TRA2B RBBP6 LUC7L2 NKTR GPATCH8	2.95e-05	625	13	5	int:NUP43
Interaction	ACIN1 interactions	RBBP6 LUC7L LUC7L2 SRSF4	3.14e-05	301	13	4	int:ACIN1
Interaction	MIR19A interactions	TRA2B TRA2A RBBP6	3.27e-05	100	13	3	int:MIR19A
Interaction	MIR19B1 interactions	TRA2B TRA2A RBBP6	3.68e-05	104	13	3	int:MIR19B1
Interaction	GSPT2 interactions	TRA2B TRA2A RBBP6	4.00e-05	107	13	3	int:GSPT2
Interaction	PRP4K interactions	TRA2B LUC7L LUC7L2 SRSF4	4.44e-05	329	13	4	int:PRP4K
Interaction	CHMP4C interactions	TRA2B TRA2A LUC7L RSRC2 SRSF4	4.65e-05	687	13	5	int:CHMP4C
Interaction	RNF113A interactions	TRA2B RBBP6 LUC7L CDK13 LUC7L2	4.81e-05	692	13	5	int:RNF113A
Interaction	SRRM1 interactions	TRA2B TRA2A LUC7L SRSF4	5.52e-05	348	13	4	int:SRRM1
Interaction	MAGEB2 interactions	RBBP6 LUC7L CDK13 NKTR	5.59e-05	349	13	4	int:MAGEB2
Interaction	PAXIP1 interactions	TRA2B TRA2A LUC7L2 SRSF4	6.23e-05	359	13	4	int:PAXIP1
Interaction	SRSF12 interactions	TRA2A LUC7L2 SRSF4	7.15e-05	130	13	3	int:SRSF12
Interaction	NKAP interactions	LUC7L LUC7L2 NKTR	7.49e-05	132	13	3	int:NKAP
Interaction	ZNF514 interactions	TRA2B TRA2A	8.01e-05	21	13	2	int:ZNF514
Interaction	TRA2B interactions	TRA2B TRA2A LUC7L2 SRSF4	8.18e-05	385	13	4	int:TRA2B
Interaction	SNRPF interactions	TRA2B TRA2A LUC7L NKTR	8.18e-05	385	13	4	int:SNRPF
Interaction	LARP1B interactions	TRA2A LUC7L2 SRSF4	8.73e-05	139	13	3	int:LARP1B
Interaction	UBE2O interactions	LUC7L CDK13 LUC7L2 PRM2 RSRC2	9.05e-05	790	13	5	int:UBE2O
Interaction	PABPC5 interactions	TRA2B TRA2A RBBP6	9.30e-05	142	13	3	int:PABPC5
Interaction	CASC3 interactions	TRA2A LUC7L LUC7L2	9.30e-05	142	13	3	int:CASC3
Interaction	SNRPD2 interactions	TRA2B LUC7L LUC7L2 NKTR	1.08e-04	414	13	4	int:SNRPD2
Interaction	NCBP3 interactions	TRA2A LUC7L2 SRSF4	1.23e-04	156	13	3	int:NCBP3
Interaction	ANTKMT interactions	LUC7L LUC7L2	1.24e-04	26	13	2	int:ANTKMT
Interaction	MEPCE interactions	TRA2B TRA2A LUC7L LUC7L2 SRSF4	1.34e-04	859	13	5	int:MEPCE
Interaction	MKRN1 interactions	TRA2A LUC7L LUC7L2	1.45e-04	165	13	3	int:MKRN1
Interaction	ZC3H14 interactions	LUC7L LUC7L2 SRSF4	1.56e-04	169	13	3	int:ZC3H14
Interaction	LARP1 interactions	TRA2A LUC7L LUC7L2 SRSF4	1.70e-04	465	13	4	int:LARP1
Interaction	EWSR1 interactions	TRA2B TRA2A RBBP6 GPATCH8 SRSF4	1.73e-04	906	13	5	int:EWSR1
Interaction	SF3A1 interactions	TRA2B TRA2A RBBP6 LUC7L2	1.78e-04	471	13	4	int:SF3A1
Interaction	SRSF5 interactions	TRA2B TRA2A CDK13 SRSF4	1.83e-04	474	13	4	int:SRSF5
Interaction	IVNS1ABP interactions	TRA2B PRICKLE1 LUC7L2	1.88e-04	180	13	3	int:IVNS1ABP
Interaction	SREK1 interactions	TRA2B LUC7L2 SRSF4	1.97e-04	183	13	3	int:SREK1
Interaction	ZRANB2 interactions	TRA2B LUC7L LUC7L2	2.52e-04	199	13	3	int:ZRANB2
Interaction	SNRPB interactions	TRA2B RBBP6 NKTR SRSF4	2.55e-04	517	13	4	int:SNRPB
Interaction	FOXA1 interactions	TRA2B TRA2A LUC7L LUC7L2	2.70e-04	525	13	4	int:FOXA1
Interaction	PRM2 interactions	LUC7L PRM2	2.81e-04	39	13	2	int:PRM2
Interaction	UBR5 interactions	TRA2A LUC7L LUC7L2 SRSF4	2.86e-04	533	13	4	int:UBR5
Interaction	SON interactions	RBBP6 NKTR SRSF4	2.87e-04	208	13	3	int:SON
Interaction	RIOK1 interactions	TRA2B LUC7L LUC7L2 SRSF4	3.50e-04	562	13	4	int:RIOK1
Interaction	PURG interactions	RBBP6 CDK13 NKTR	3.52e-04	223	13	3	int:PURG
Interaction	CLK4 interactions	RBBP6 SRSF4	3.58e-04	44	13	2	int:CLK4
Interaction	FOLR1 interactions	RBBP6 LUC7L LUC7L2	3.71e-04	227	13	3	int:FOLR1
Interaction	CD2BP2 interactions	NKTR GPATCH8 SRSF4	3.96e-04	232	13	3	int:CD2BP2
Interaction	NGRN interactions	TRA2B TRA2A SRSF4	4.11e-04	235	13	3	int:NGRN
Cytoband	Ensembl 112 genes in cytogenetic band chr16p13	LUC7L PRM2	6.26e-03	426	13	2	chr16p13
GeneFamily	RNA binding motif containing	TRA2B TRA2A SRSF4	8.64e-05	213	8	3	725
Coexpression	NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN	TRA2A RBBP6 LUC7L2 NKTR RSRC2	1.37e-06	432	13	5	M41149
Coexpression	GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_DN	TRA2B TRA2A CDK13 RSRC2	2.18e-06	199	13	4	M6060
Coexpression	FAN_OVARY_CL15_SMALL_ANTRAL_FOLLICLE_GRANULOSA_CELL	TRA2B TRA2A RBBP6 LUC7L RSRC2	9.63e-06	644	13	5	M41717
Coexpression	GSE3039_NKT_CELL_VS_ALPHAALPHA_CD8_TCELL_UP	TRA2A LUC7L RSRC2	1.18e-04	200	13	3	M6473
Coexpression	GSE23925_LIGHT_ZONE_VS_DARK_ZONE_BCELL_DN	TRA2B LUC7L2 RSRC2	1.18e-04	200	13	3	M7878
Coexpression	TABULA_MURIS_SENIS_PANCREAS_PANCREATIC_BETA_CELL_AGEING	LUC7L2 NKTR RSRC2	1.41e-04	212	13	3	MM3816
Coexpression	THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_DN	TRA2A LUC7L NKTR SRSF4	2.04e-04	634	13	4	M40866
Coexpression	TABULA_MURIS_SENIS_LIVER_NK_CELL_AGEING	TRA2B LUC7L2 RSRC2	3.46e-04	288	13	3	MM3751
Coexpression	BENPORATH_SOX2_TARGETS	TRA2A NKTR RSRC2 SRSF4	3.56e-04	734	13	4	M3835
Coexpression	PUJANA_ATM_PCC_NETWORK	TRA2B TRA2A RBBP6 CDK13 NKTR	3.80e-04	1394	13	5	M9585
Coexpression	GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP	TRA2B RSRC2	3.82e-04	59	13	2	M17730
Coexpression	FAN_OVARY_CL5_HEALTHY_SELECTABLE_FOLLICLE_THECAL_CELL	TRA2B RBBP6 RSRC2	4.62e-04	318	13	3	M41707
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	TRA2B RBBP6 CDK13 GPATCH8 RSRC2	5.20e-04	1492	13	5	M40023
Coexpression	NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_NEGATIVE	LUC7L2 NKTR RSRC2	6.80e-04	363	13	3	M41103
Coexpression	JOHNSTONE_PARVB_TARGETS_3_DN	TRA2B TRA2A LUC7L2 NKTR	6.99e-04	877	13	4	M2241
Coexpression	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP	CDK13 SRSF4	8.11e-04	86	13	2	M19610
ToppCell	10x3'2.3-week_17-19-Lymphocytic_B\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	TRA2B TRA2A CDK13 RSRC2	2.52e-07	198	13	4	5f465cf5c7493e32d9afe9e9d05757d0a95acc33
ToppCell	10x3'2.3-week_17-19-Lymphocytic_B-B_lineage\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	TRA2B TRA2A CDK13 RSRC2	2.52e-07	198	13	4	77ce3fe1ab161c0faf8987e73a64ab61294b9255
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TRA2B CDK13 NKTR RSRC2	2.63e-07	200	13	4	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	COVID-19\|World / Disease, condition lineage and cell class	TRA2B RBBP6 CDK13 RSRC2	2.63e-07	200	13	4	7dec470c379cd89f05a0f37c8628b21f136e52f0
ToppCell	3'_v3-lymph-node_spleen\|World / Manually curated celltypes from each tissue	TRA2B CDK13 NKTR	1.50e-05	171	13	3	7aae88da5b37c20f10118325a048f08906be994c
ToppCell	Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Nptxr-Excitatory_Neuron.Slc17a7.Nptxr-Drd1_(Deep_layer_pyramidal_cells)\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	RBBP6 CDK13 LUC7L2	1.64e-05	176	13	3	3c76a5c4ca2b378667cb155fbb9675519572b35d
ToppCell	ILEUM-inflamed-(1)_T_cell-(1)_CD8_Trm\|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	TRA2B TRA2A NKTR	1.87e-05	184	13	3	cef3ee2a4a0af961aa3b4c92150d423e841ae8c1
ToppCell	Brain_organoid-organoid_Kanton_Nature\|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type.	TRA2B LUC7L2 NKTR	1.90e-05	185	13	3	857c7ca8493e91ef1d0078ddafd6082020f9b169
ToppCell	COVID-19_Convalescent-PLT_4\|World / Disease Group and Platelet Clusters	TRA2B TRA2A RSRC2	1.93e-05	186	13	3	5954a1e3ffafb33f2a9bc87af3343f304fda4c92
ToppCell	ILEUM-inflamed-(3)_MNP-(3)_moDC\|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	TRA2B TRA2A NKTR	1.96e-05	187	13	3	0099def970fbc828756fbf853eca2ce77b8cd342
ToppCell	ILEUM-non-inflamed-(1)_T_cell-(1)_CD8_Trm\|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	TRA2B TRA2A NKTR	2.02e-05	189	13	3	2c8a2fb76ea002bac554bc1c761ce960b5e116e1
ToppCell	COVID-19_Mild-PLT_4\|World / Disease Group and Platelet Clusters	TRA2B TRA2A RSRC2	2.15e-05	193	13	3	98a52523aa1efd5d14a2878ed106828a80a33aa2
ToppCell	COVID-19_Convalescent-PLT_4\|COVID-19_Convalescent / Disease Group and Platelet Clusters	TRA2B TRA2A RSRC2	2.19e-05	194	13	3	ce1fad4e76a87f0c35e430ed1f2262395df882fd
ToppCell	10x3'2.3\|World / cell types per 3 fetal stages;per 3',per 5'	TRA2B TRA2A RSRC2	2.19e-05	194	13	3	fc7ed8350ffe1475b8934dfbb107b51991876b0b
ToppCell	COVID-19_Severe-PLT_4\|World / Disease Group and Platelet Clusters	TRA2B TRA2A RSRC2	2.25e-05	196	13	3	ad43efdd4d73b6615f65f06a315b33576e317473
ToppCell	10x3'2.3-week_17-19\|World / cell types per 3 fetal stages;per 3',per 5'	TRA2B TRA2A RSRC2	2.29e-05	197	13	3	f5cfad0b42d0f817e22cc78b9bfb2b4b7e4330ed
ToppCell	H1299-infected-SARSCoV2\|infected / Cell line, Condition and Strain	RBBP6 NKTR RSRC2	2.29e-05	197	13	3	0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e
ToppCell	Control-PLT_4\|Control / Disease Group and Platelet Clusters	TRA2B TRA2A RSRC2	2.32e-05	198	13	3	387fd3037fd52e4d4c42de0588767e58af228b59
ToppCell	COVID-19_Severe-PLT_4\|COVID-19_Severe / Disease Group and Platelet Clusters	TRA2B TRA2A RSRC2	2.32e-05	198	13	3	abfddbee99ef8c7719e6e6f62571e9be030e4acf
ToppCell	COVID-19_Mild-PLT_4\|COVID-19_Mild / Disease Group and Platelet Clusters	TRA2B TRA2A RSRC2	2.32e-05	198	13	3	3d8c33dba759df0974aeb2b9a6b5167ae7a18e1f
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	LUC7L CDK13 NKTR	2.36e-05	199	13	3	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	Globus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cyth3_(Cyth3)\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	TRA2B SRSF4	8.74e-04	153	13	2	88ca2d2c2ab19fbee13e18951b993ee05dd30f67
ToppCell	Globus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cyth3_(Cyth3)-\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	TRA2B SRSF4	8.74e-04	153	13	2	553dff9688a1996d8f4ba16e60c683593d781389
ToppCell	facs-Aorta-Heart-24m-Endothelial-coronary_vascular_endothelial_cell\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LUC7L2 PRM2	1.00e-03	164	13	2	5ee3729fab794d7acb172d14ec5d91aa1a61cd61
ToppCell	(03)_Secretory-(4)_1wkpi\|(03)_Secretory / shred by cell type and Timepoint	TRA2B LUC7L2	1.14e-03	175	13	2	06b52f85baa31b55bb31477244892b6da79fe2c9
ToppCell	3'_v3\|World / Manually curated celltypes from each tissue	TRA2B NKTR	1.18e-03	178	13	2	42502f14d9c756df8104900ac6484477b885d3d9
ToppCell	(00)_Basal-(4)_1wkpi\|(00)_Basal / shred by cell type and Timepoint	TRA2B TRA2A	1.27e-03	185	13	2	bf82ba905e5eee1c39a2731702071d3de10a78b8
ToppCell	droplet-Liver-Hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRICKLE1 CDK13	1.29e-03	186	13	2	90d53c2597a9f3a2b39afba75adfc54f1ca0a4db
ToppCell	droplet-Liver-Hepatocytes-24m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRICKLE1 CDK13	1.29e-03	186	13	2	2cae34336f184f971f7c8684cc27c23a4e7369ed
ToppCell	droplet-Bladder-nan\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRA2B RSRC2	1.30e-03	187	13	2	663991a8afe652e92363b64bcbd68c14d0307f0e
ToppCell	droplet-Tongue-nan\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRA2B RSRC2	1.31e-03	188	13	2	d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd
ToppCell	ILEUM-inflamed-(5)_Plasma-(5)_IgA_plasma_cells\|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	TRA2A NKTR	1.33e-03	189	13	2	a0634d72bfdd5f93877724ed6480b50a3a046f71
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-B_lymphocytic-naive_B_cell\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	PRICKLE1 CDK13	1.34e-03	190	13	2	a7498fe55b7810c482291db782dc5282675d246a
ToppCell	368C-Myeloid-Dendritic-cDC2\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	TRA2B RSRC2	1.36e-03	191	13	2	85dba3a8a52307df52d1d78a6f278501298f3067
ToppCell	10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-pro_B_progenitor\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	TRA2B CDK13	1.36e-03	191	13	2	40813c397f533c2f4a6359a77757f736b6d9e07d
ToppCell	368C-Myeloid-Dendritic\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	TRA2B RSRC2	1.36e-03	191	13	2	29f9db28cee6476141b0773682c66e6be940de46
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25\|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k)	NKTR RSRC2	1.36e-03	191	13	2	1ecd9849d14d5ebf3daf610e83fb50820cafd3ed
ToppCell	10x3'2.3-week_12-13-Myeloid_macrophage-stroma-monocytoid_macrophage\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	TRA2B RSRC2	1.36e-03	191	13	2	8a67dc87c926c826a09cf6469c8ebf90c80b06db
ToppCell	metastatic_Brain-T/NK_cells-Exhausted_CD8+_T\|T/NK_cells / Location, Cell class and cell subclass	TRA2B TRA2A	1.36e-03	191	13	2	2ffd40ebf1d63e61a97208ddcbeb6a86e409f9d8
ToppCell	droplet-Pancreas-Endocrine\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LUC7L2 NKTR	1.37e-03	192	13	2	0dfd1e9896c34aee0f842f8de5d0e3af62a15f68
ToppCell	Control-PLT_1\|World / Disease Group and Platelet Clusters	RBBP6 LUC7L2	1.37e-03	192	13	2	f595eba81911eb860dce964f1d8269287f50d3ea
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	LUC7L NKTR	1.37e-03	192	13	2	47646d7e4990be85072987f92bf18d52f8da752e
ToppCell	severe-low-quality_cells\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	CDK13 NKTR	1.38e-03	193	13	2	9337bc93e3904c7fc7c93c328518bcd6453b1e8c
ToppCell	droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LUC7L2 NKTR	1.38e-03	193	13	2	471e65f02937bc18d7c5facdacdf1df58cf0f839
ToppCell	droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LUC7L2 NKTR	1.38e-03	193	13	2	fe451b3295d77b2bd1ac25cf29310c85835a45fe
ToppCell	droplet-Pancreas-Endocrine-21m\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LUC7L2 NKTR	1.40e-03	194	13	2	3a3ecedcdc7691cf21775818b598208fcb980c29
ToppCell	10x3'2.3-week_14-16-Lymphocytic_B-B_lineage-pro_B_progenitor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	CDK13 RSRC2	1.40e-03	194	13	2	f64da5f62e29253d60b9546edf734ba5c17daae1
ToppCell	droplet-Pancreas-Endocrine-21m-Epithelial\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LUC7L2 NKTR	1.40e-03	194	13	2	0b023de48ed8a550d169bbe954881eb04bf4f981
ToppCell	lymphoid-T_cell-unlabelled(multiplets)\|World / Lineage, cell class and subclass	TRA2B RSRC2	1.43e-03	196	13	2	78b006922307c154622d71fcbc79ae5eed3f4b23
ToppCell	CV-Moderate-6\|CV / Virus stimulation, Condition and Cluster	TRA2A RBBP6	1.43e-03	196	13	2	7bced0cc2112697593c478fa291b8ed3941fb811
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic\|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)	NKTR GPATCH8	1.43e-03	196	13	2	a9157809122e6fc5783a291522f103bef30943e4
ToppCell	COVID-19_Mild-Classical_Monocyte-cMono_4\|Classical_Monocyte / Disease condition and Cell class	NKTR SRSF4	1.44e-03	197	13	2	e666f6580e9a20b5e550f02125706db17eec8510
ToppCell	COVID-19_Mild\|World / Disease group, lineage and cell class	NKTR RSRC2	1.44e-03	197	13	2	5c33454b10023decd2f5ccda9229b6512659711e
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Mesenchymal\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TRA2B PRICKLE1	1.44e-03	197	13	2	5f6fce382f273e789ffbb75b63e9b4e87519918e
ToppCell	5'-GW_trimst-1.5-LargeIntestine\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TRA2B PRICKLE1	1.44e-03	197	13	2	0b2ad6a933ff1a325649cc8f139380fd158a1d42
ToppCell	severe-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	CDK13 NKTR	1.44e-03	197	13	2	57ebd552f10d6278623b52a3d484d4b91ae1d028
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	TRA2A NKTR	1.44e-03	197	13	2	ef2d1f56acd0be43e69bba7f73f6909ba87f1cb3
ToppCell	PBMC-Mild\|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	NKTR RSRC2	1.46e-03	198	13	2	28ef3fc4c17dcb765537b75917f7db78baa522db
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	TRA2A NKTR	1.46e-03	198	13	2	33a3b279c9ff3b762e52d060dae062167ca2239b
ToppCell	PBMC_fresh-frozen\|World / Compartment, severity and other cell annotations on 10x 3' data (130k)	TRA2B NKTR	1.46e-03	198	13	2	dcc223a0396b8b673e4ed8c6733ec6cd74e9a03a
ToppCell	PBMC-Mild\|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09)	NKTR RSRC2	1.46e-03	198	13	2	44417089b62056269cac38d3134ff209c05b7007
ToppCell	10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-pre_B_progenitor\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	TRA2A RSRC2	1.47e-03	199	13	2	dd94e42b62af7cbd69c472681d3c758552694ae2
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-immature_mesenchymal_cell\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TRA2B PRICKLE1	1.47e-03	199	13	2	bb201deb281619113edcd1de2af2d3eb21b967b8
ToppCell	human_hepatoblastoma-Tumor_cells-T9\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	TRA2B RSRC2	1.47e-03	199	13	2	e9c83555d2197b740797a9f33b64f8f7a7ba1ee2
ToppCell	severe\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TRA2B RSRC2	1.48e-03	200	13	2	accc618d6b960bff30cb531c1226295bfc8650f6
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate\|6m / Sample Type, Dataset, Time_group, and Cell type.	RBBP6 RSRC2	1.48e-03	200	13	2	7c261e39ac30b318511373ab7302aa53b8b81b9c
Computational	Neighborhood of HDAC1	TRA2B TRA2A RBBP6 SRSF4	2.08e-06	110	10	4	GNF2_HDAC1
Computational	Neighborhood of CSNK1A1	LUC7L2 RSRC2	4.83e-04	36	10	2	GCM_CSNK1A1
Computational	Neighborhood of RAD21	TRA2B SRSF4	5.10e-04	37	10	2	GCM_RAD21
Computational	Genes upregulated in subsets of cells of a given type within various tumors	CDK13 NKTR	9.32e-04	50	10	2	GAVISH_3CA_METAPROGRAM_B_CELLS_B_CELLS_1
Computational	Neighborhood of PPP1CC	TRA2B SRSF4	1.17e-03	56	10	2	GCM_PPP1CC
Computational	Neighborhood of DDX5	TRA2B SRSF4	1.57e-03	65	10	2	GCM_DDX5
Computational	Neighborhood of RBBP6	RBBP6 RSRC2	1.82e-03	70	10	2	GNF2_RBBP6
Computational	Neighborhood of HEAB	CDK13 GPATCH8	2.55e-03	83	10	2	MORF_HEAB
Drug	AC1NRA5C	TRA2B TRA2A CDK13 SRSF4	2.23e-06	174	13	4	CID005287709
Drug	Lanatoside C [17575-22-3]; Up 200; 4uM; PC3; HT_HG-U133A	TRA2B TRA2A RSRC2	9.08e-05	159	13	3	4328_UP
Drug	Digoxin [20830-75-5]; Up 200; 5.2uM; MCF7; HT_HG-U133A	TRA2A GPATCH8 RSRC2	1.03e-04	166	13	3	5324_UP
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA	CDK13 LUC7L2 SRSF4	1.15e-04	172	13	3	1072_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	CDK13 LUC7L2 SRSF4	1.15e-04	172	13	3	6993_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	CDK13 LUC7L2 SRSF4	1.17e-04	173	13	3	4565_DN
Drug	SAHA; Down 200; 10uM; MCF7; HT_HG-U133A	CDK13 LUC7L2 SRSF4	1.19e-04	174	13	3	5580_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA	CDK13 LUC7L2 SRSF4	1.21e-04	175	13	3	1014_DN
Drug	SAHA; Down 200; 10uM; MCF7; HT_HG-U133A_EA	CDK13 LUC7L2 SRSF4	1.21e-04	175	13	3	1058_DN
Drug	ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA	RBBP6 NKTR GPATCH8	1.25e-04	177	13	3	985_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	CDK13 LUC7L2 SRSF4	1.27e-04	178	13	3	5086_DN
Drug	Piperlongumine [20069-09-4]; Up 200; 12.6uM; HL60; HG-U133A	TRA2B RBBP6 RSRC2	1.29e-04	179	13	3	1764_UP
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A	CDK13 LUC7L2 SRSF4	1.31e-04	180	13	3	5981_DN
Drug	LY 294002; Up 200; 10uM; PC3; HT_HG-U133A	TRA2A NKTR ZNF580	1.33e-04	181	13	3	1236_UP
Drug	radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	RBBP6 NKTR ZNF580	1.56e-04	191	13	3	1057_DN
Drug	0317956-0000 [391210-11-0]; Up 200; 1uM; MCF7; HT_HG-U133A	TRA2A CDK13 NKTR	1.59e-04	192	13	3	3858_UP
Drug	17-DMAG; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	RBBP6 NKTR SRSF4	1.61e-04	193	13	3	1051_DN
Drug	Betahistine mesylate [54856-23-4]; Down 200; 17.2uM; MCF7; HT_HG-U133A	TRA2B TRA2A RSRC2	1.61e-04	193	13	3	2833_DN
Drug	Cephalosporanic acid, 7-amino [957-68-6]; Down 200; 14.6uM; PC3; HT_HG-U133A	CDK13 PRM2 ZNF580	1.64e-04	194	13	3	4242_DN
Drug	Amoxapine [14028-44-5]; Down 200; 12.8uM; PC3; HG-U133A	TRA2B CDK13 NKTR	1.71e-04	197	13	3	1931_DN
Drug	Cephalosporanic acid, 7-amino [957-68-6]; Down 200; 14.6uM; HL60; HT_HG-U133A	TRA2A CDK13 RSRC2	1.71e-04	197	13	3	1322_DN
Drug	Novobiocin sodium salt [1476-53-5]; Down 200; 6.4uM; PC3; HT_HG-U133A	TRA2A CDK13 NKTR	1.74e-04	198	13	3	4569_DN
Drug	Midecamycin [35457-80-8]; Down 200; 5uM; PC3; HG-U133A	CDK13 ZNF580 GPATCH8	1.74e-04	198	13	3	1943_DN
Drug	Alfuzosin hydrochloride [81403-68-1]; Up 200; 9.4uM; MCF7; HT_HG-U133A	TRA2A PRM2 NKTR	1.76e-04	199	13	3	3203_UP
Drug	PCI 5002	TRA2B RBBP6 LUC7L RSRC2	6.10e-04	735	13	4	ctd:C568608
Drug	Sodium Fluoride	RBBP6 LUC7L PRM2 SRSF4	1.49e-03	933	13	4	ctd:D012969
Drug	Digoxigenin [1672-46-4]; Up 200; 10.2uM; MCF7; HT_HG-U133A	TRA2A RSRC2	3.64e-03	160	13	2	5275_UP
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	LUC7L2 SRSF4	3.68e-03	161	13	2	4768_DN
Drug	15d-PGJ2; Up 200; 10uM; MCF7; HT_HG-U133A_EA	TRA2B RBBP6	3.73e-03	162	13	2	1069_UP
Drug	Lanatoside C [17575-22-3]; Up 200; 4uM; PC3; HT_HG-U133A	TRA2A RSRC2	3.73e-03	162	13	2	3771_UP
Drug	Proscillaridin A [466-06-8]; Up 200; 7.6uM; MCF7; HT_HG-U133A	TRA2A RSRC2	3.73e-03	162	13	2	7340_UP
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	LUC7L2 SRSF4	3.77e-03	163	13	2	5594_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	LUC7L2 SRSF4	3.77e-03	163	13	2	7285_DN
Drug	testosterone enanthate	TRA2A NKTR GPATCH8	3.79e-03	575	13	3	ctd:C004648
Drug	Lanatoside C [17575-22-3]; Up 200; 4uM; MCF7; HT_HG-U133A	TRA2A RSRC2	3.82e-03	164	13	2	3852_UP
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	LUC7L2 SRSF4	3.86e-03	165	13	2	6085_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	LUC7L2 SRSF4	3.86e-03	165	13	2	2835_DN
Drug	Helveticoside [630-64-8]; Up 200; 7.4uM; MCF7; HT_HG-U133A	TRA2A RSRC2	3.86e-03	165	13	2	3851_UP
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	LUC7L2 SRSF4	3.86e-03	165	13	2	5625_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	LUC7L2 SRSF4	3.91e-03	166	13	2	2247_DN
Drug	2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline	RBBP6 CDK13	3.91e-03	166	13	2	ctd:C036990
Drug	Strophanthidin [66-28-4]; Up 200; 9.8uM; PC3; HT_HG-U133A	TRA2A RSRC2	3.91e-03	166	13	2	5826_UP
Drug	SAHA; Down 200; 10uM; MCF7; HT_HG-U133A	LUC7L2 SRSF4	3.96e-03	167	13	2	5217_DN
Drug	Strophantine octahydrate [11018-89-6]; Up 200; 5.4uM; PC3; HT_HG-U133A	TRA2A RSRC2	3.96e-03	167	13	2	6680_UP
Drug	Sanguinarine [2447-54-3]; Up 200; 12uM; HL60; HT_HG-U133A	TRA2B RSRC2	3.96e-03	167	13	2	2927_UP
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	LUC7L2 SRSF4	4.00e-03	168	13	2	3868_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	LUC7L2 SRSF4	4.00e-03	168	13	2	6820_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	LUC7L2 SRSF4	4.05e-03	169	13	2	5231_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	LUC7L2 SRSF4	4.05e-03	169	13	2	5572_DN
Drug	Digoxin [20830-75-5]; Up 200; 5.2uM; PC3; HT_HG-U133A	TRA2A RSRC2	4.05e-03	169	13	2	6724_UP
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	LUC7L2 SRSF4	4.10e-03	170	13	2	7043_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	LUC7L2 SRSF4	4.10e-03	170	13	2	3791_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	LUC7L2 SRSF4	4.10e-03	170	13	2	3746_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	LUC7L2 SRSF4	4.10e-03	170	13	2	1050_DN
Drug	SAHA; Down 200; 10uM; MCF7; HT_HG-U133A_EA	CDK13 LUC7L2	4.14e-03	171	13	2	1000_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A	LUC7L2 SRSF4	4.14e-03	171	13	2	1234_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	LUC7L2 SRSF4	4.14e-03	171	13	2	6879_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	LUC7L2 SRSF4	4.14e-03	171	13	2	4954_DN
Drug	Strophantine octahydrate [11018-89-6]; Up 200; 5.4uM; MCF7; HT_HG-U133A	TRA2A RSRC2	4.14e-03	171	13	2	5026_UP
Drug	Bisacodyl [603-50-9]; Up 200; 11uM; MCF7; HT_HG-U133A	TRA2A RSRC2	4.14e-03	171	13	2	3297_UP
Drug	Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	LUC7L2 SRSF4	4.19e-03	172	13	2	1637_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A	LUC7L2 SRSF4	4.19e-03	172	13	2	6439_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	LUC7L2 SRSF4	4.19e-03	172	13	2	4112_DN
Drug	calmidazolium chloride; Up 200; 5uM; MCF7; HT_HG-U133A_EA	PRM2 NKTR	4.19e-03	172	13	2	906_UP
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	LUC7L2 SRSF4	4.19e-03	172	13	2	2330_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	LUC7L2 SRSF4	4.24e-03	173	13	2	5336_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	LUC7L2 SRSF4	4.24e-03	173	13	2	4665_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	LUC7L2 SRSF4	4.24e-03	173	13	2	2084_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A	LUC7L2 SRSF4	4.24e-03	173	13	2	4458_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	LUC7L2 SRSF4	4.29e-03	174	13	2	6579_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A	LUC7L2 SRSF4	4.29e-03	174	13	2	7105_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	LUC7L2 SRSF4	4.29e-03	174	13	2	5745_DN
Drug	HC toxin from Helminthosporium carbonum; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	LUC7L2 SRSF4	4.29e-03	174	13	2	909_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	LUC7L2 SRSF4	4.29e-03	174	13	2	5945_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	LUC7L2 SRSF4	4.29e-03	174	13	2	3993_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	LUC7L2 SRSF4	4.29e-03	174	13	2	3462_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	LUC7L2 SRSF4	4.29e-03	174	13	2	5693_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	LUC7L2 SRSF4	4.29e-03	174	13	2	1659_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	LUC7L2 SRSF4	4.29e-03	174	13	2	5065_DN
Drug	Lanatoside C [17575-22-3]; Up 200; 4uM; MCF7; HT_HG-U133A	TRA2A RSRC2	4.29e-03	174	13	2	6048_UP
Drug	Strophantine octahydrate [11018-89-6]; Up 200; 5.4uM; HL60; HT_HG-U133A	RBBP6 RSRC2	4.29e-03	174	13	2	1302_UP
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	LUC7L2 SRSF4	4.33e-03	175	13	2	6736_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	LUC7L2 SRSF4	4.33e-03	175	13	2	4072_DN
Drug	Cephaeline dihydrochloride heptahydrate [6487-30-5]; Up 200; 6uM; PC3; HT_HG-U133A	TRA2B RSRC2	4.33e-03	175	13	2	4651_UP
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A	LUC7L2 SRSF4	4.33e-03	175	13	2	5908_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	LUC7L2 SRSF4	4.33e-03	175	13	2	7387_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	LUC7L2 SRSF4	4.33e-03	175	13	2	3787_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	LUC7L2 SRSF4	4.33e-03	175	13	2	6316_DN
Drug	SAHA; Down 200; 10uM; PC3; HT_HG-U133A	LUC7L2 SRSF4	4.33e-03	175	13	2	1220_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	LUC7L2 SRSF4	4.33e-03	175	13	2	5935_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	LUC7L2 SRSF4	4.33e-03	175	13	2	7236_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A	LUC7L2 SRSF4	4.38e-03	176	13	2	6546_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	CDK13 LUC7L2	4.38e-03	176	13	2	2639_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	LUC7L2 SRSF4	4.38e-03	176	13	2	4632_DN

Protein segments in the cluster

Peptide	Gene	Start	Entry
SSRHSRSRSRHRLSR	CDK13	416	Q14004
RDRHRRHRSRSRSHS	LUC7L	296	Q9NQ29
RHRSRSRSHSRGHRR	LUC7L	301	Q9NQ29
SGRRHSSHRSSRRSY	GPATCH8	856	Q9UKJ3
SRSRSHGYHRSRSRS	RBBP6	746	Q7Z6E9
RGSRSHHHRRRRSRK	PRICKLE1	666	Q96MT3
HRHRSRSSSRSRSRS	LUC7L2	301	Q9Y383
HRHRTRSRSRTRSRS	RSRC2	186	Q7L4I2
SRSRSHSRSRSRSRH	SRSF4	186	Q08170
RHRTRSVSYSHSRSR	NKTR	1326	P30414
SHYRRRHCSRRRLHR	PRM2	51	P04554
SRSRSRRHSHRRYTR	TRA2A	56	Q13595
RRHSHRRYTRSRSHS	TRA2A	61	Q13595
RRYTRSRSHSHSHRR	TRA2A	66	Q13595
SRSHSHSHRRRSRSR	TRA2A	71	Q13595
HSHRRRSRSRSYTPE	TRA2A	76	Q13595
RSSHLSRHRATHRAR	ZNF580	131	Q9UK33
RHYTRSRSRSRSHRR	TRA2B	66	P62995